Impact of response to prior chemotherapy (RTPC) on outcomes in second-line therapy for advanced urothelial carcinoma (UC): Implications for trial design. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pond, Gregory
  • Bellmunt, Joaquim
  • Fougeray, Ronan
  • Choueiri, Toni K
  • Qu, Angela Q
  • Salhi, Yacine
  • Niegisch, Guenter
  • Albers, Peter
  • Di Lorenzo, Giuseppe
  • Galsky, Matt D
  • Necchi, Andrea
  • Sonpavde, Guru

publication date

  • May 20, 2013